Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019
Jayanthi Mathaiyan1★, Prasanth Ganesan2, Tamilarasu Kadhiravan3, Nishanthi Anandabaskar4★ Corresponding author
- 1Department of Pharmacology, JIPMER, Puducherry, India.
- 2Department of Medical Oncology, JIPMER, Puducherry, India.
- 3Department of Medicine, JIPMER, Puducherry, India.
- 4Department of Pharmacology, Sri Manakula Vinayagar Medical College Hospital, Puducherry, India.
CORRESPONDENCE
Jayanthi Mathaiyan
Department of Pharmacology, JIPMER, Puducherry, India.
Received: 24-12-2020; Revised: 26-12-2020; Accepted: 29-12-2020.
Volume 11, Issue 4 · pp. 148–150 · PUBLISHED 2020 · DOI: 10.4103/jpp.jpp_173_20
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Mathaiyan, J., Ganesan, P., Kadhiravan, T., & Anandabaskar, N. (2020). Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 148–150. https://doi.org/10.4103/jpp.jpp_173_20
